Proyecto cofinanciado por la Unión Europea – FEDER
Altan Pharmaceuticals, S.A. (Grupo Ethypharm) ha recibido una ayuda del programa de Incentivos Regionales para la ampliación de su capacidad productiva
Más información

Ethypharm - Newsroom 2022

Do you have
any question?

Newsroom 2022

Press releases

All

Bruno Ultra BARCELOS is appointed Managing Director of Ethypharm UK

Denis DELVAL is appointed President and CEO of the Ethypharm Group

Ethypharm is sad to announce the death of Bertrand DELUARD, President and CEO of the Ethypharm Group.

Ethypharm is the first European pharmaceutical laboratory to be awarded the LUCIE 26000 label for its CSR commitment.

Ethypharm has obtained marketing authorisations for the first Immediate Release orodispersible tablets of morphine in Germany, France and the United Kingdom.

Ethypharm consolidates its European presence with the integration of Altan, now led by Manuel Casegas as its General Manager

Ethypharm consolidates its European presence with the integration of Altan, now led by Manuel Casegas as its General Manager

Prescriptions of medical cannabis dried flowers have started for patients included in the French pilot programme

Ethypharm reinforces its late-stage R&D pipeline with a novel acute treatment of migraine

Media enquiries

First name*

Last name*

Email address*

Phone number*

Media*

Country*

Your message*

*All fields must be filled in

By submitting this form, I agree that any information I give will be used by Ethypharm for the purpose of, and limited to, processing my request. In accordance with the European regulation n°2016/679 of the European Parliament and of the Council of 27 April 2016 relating to the protection of personal data referred to as «GDPR” and effective as of the 25th day of May 2018, I validate that I have the right to access the data concerning me and to have it rectified or deleted by sending a request by selecting “data privacy” on the form on the contact page. To access the page, click here.

Send